OPKO Health, Inc. (TLV: OPK)
Israel
· Delayed Price · Currency is ILS · Price in ILA
570.30
-12.60 (-2.16%)
Dec 19, 2024, 5:24 PM IDT
OPKO Health Revenue
OPKO Health had revenue of $173.63M USD in the quarter ending September 30, 2024, a decrease of -2.78%. This brings the company's revenue in the last twelve months to $711.41M, down -17.94% year-over-year. In the year 2023, OPKO Health had annual revenue of $863.50M, down -14.01%.
Revenue (ttm)
$711.41M
Revenue Growth
-17.94%
P/S Ratio
n/a
Revenue / Employee
$181.02K
Employees
3,930
Market Cap
3.78B ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 863.50M | -140.70M | -14.01% |
Dec 31, 2022 | 1.00B | -770.52M | -43.42% |
Dec 31, 2021 | 1.77B | 339.31M | 23.64% |
Dec 31, 2020 | 1.44B | 533.48M | 59.15% |
Dec 31, 2019 | 901.94M | -88.33M | -8.92% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionOPKO Health News
- 4 weeks ago - NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo - PRNewsWire
- 5 weeks ago - NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 Results - PRNewsWire
- 6 weeks ago - Opko Health (OPK) Q3 2024 Earnings Call Transcript - The Motley Fool
- 6 weeks ago - OPKO Health, Inc. (OPK) Q3 2024 Earnings Conference Call Transcript - Seeking Alpha
- 2 months ago - ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program - GlobeNewsWire
- 2 months ago - NextPlat Secures Four-Year Extension of OPKO Healthcare E-Commerce Program in China and Agrees to the Expansion of the Program into Japan - PRNewsWire
- 3 months ago - OPKO Health's ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical Development - Benzinga
- 3 months ago - Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health - PRNewsWire